At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
FBT First Trust NYSE Arca Biotechnology Index Fund
Market Closed 08-21 16:00:00 EDT
270.95
+2.82
+1.05%
盘后270.94
-0.01+0.00%
19:30 EDT
High272.80Low269.08Vol37.99K
Open269.08D1 Closing268.13Amplitude1.39%
Mkt Cap2.94BTradable Cap2.94BTotal Shares10.85M
T/O10.31MT/O Rate0.35%Tradable Shares10.85M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Analysts Offer Insights on Healthcare Companies: Corcept Therapeutics (CORT), Alvotech (ALVO) and Abbott Laboratories (ABT)
TIPRANKS  ·  08-21 19:00
Analysts Offer Insights on Healthcare Companies: Corcept Therapeutics (CORT), Alvotech (ALVO) and Abbott Laboratories (ABT)
Corcept Therapeutics Director David L. Mahoney Sells 103,606 Shares Worth $12.26 Million
Reuters  ·  08-21 04:30
Corcept Therapeutics Director David L. Mahoney Sells 103,606 Shares Worth $12.26 Million
Patent Cliffs Drive Pharma Expansion as Biotech M&A and IPO Markets Stage a Comeback
Stock News  ·  08-19
Patent Cliffs Drive Pharma Expansion as Biotech M&A and IPO Markets Stage a Comeback
Corcept Chief Business Officer Gary Charles Robb Sells 10,000 Shares for $1.16 Million
Reuters  ·  08-19
Corcept Chief Business Officer Gary Charles Robb Sells 10,000 Shares for $1.16 Million
BMO starts Exelixis at Market Perform into patent cliff
TIPRANKS  ·  08-19
BMO starts Exelixis at Market Perform into patent cliff
Bruker Nano EVP, President Mark Munch Disposes of 4,984 Bruker Shares for $288,636.8
Reuters  ·  08-19
Bruker Nano EVP, President Mark Munch Disposes of 4,984 Bruker Shares for $288,636.8
Genprex selects manufacturing organization for diabetes gene therapy
TIPRANKS  ·  08-18
Genprex selects manufacturing organization for diabetes gene therapy
Corcept Therapeutics Incorporated : Truist Securities Assumes Coverage with Buy Rating; Target Price $164 vs $50
THOMSON REUTERS  ·  08-18
Corcept Therapeutics Incorporated : Truist Securities Assumes Coverage with Buy Rating; Target Price $164 vs $50
Alkermes SVP, Chief Commercial Officer Christian Todd Nichols Sells 7,576 Shares for $374,301.99
Reuters  ·  08-18
Alkermes SVP, Chief Commercial Officer Christian Todd Nichols Sells 7,576 Shares for $374,301.99
CANbridge Wins Taiwan NHIA Reimbursement for Rare Disease Drug Livmarli
TIPRANKS  ·  08-18
CANbridge Wins Taiwan NHIA Reimbursement for Rare Disease Drug Livmarli
NEO Battery Raises $4 Million to Expand South Korean Battery Manufacturing
TIPRANKS  ·  08-15
NEO Battery Raises $4 Million to Expand South Korean Battery Manufacturing
Bruker Board Declares Quarterly Cash Dividend for Shareholders
TIPRANKS  ·  08-15
Bruker Board Declares Quarterly Cash Dividend for Shareholders
Bruker Declares Quarterly Cash Dividend of $0.05 a Share
Reuters  ·  08-15
Bruker Declares Quarterly Cash Dividend of $0.05 a Share
Press Release: Caribou Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update
Dow Jones  ·  08-14
Press Release: Caribou Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update
Corcept Chief Development Officer William Guyer Disposes of Common Shares Worth $1.85 Million
Reuters  ·  08-13
Corcept Chief Development Officer William Guyer Disposes of Common Shares Worth $1.85 Million
Alkermes Cuts Interest Spreads on $1.52 Billion Term Loan Facilities Via Credit Agreement Amendment
Reuters  ·  08-12
Alkermes Cuts Interest Spreads on $1.52 Billion Term Loan Facilities Via Credit Agreement Amendment
Alkermes - Enters Amendment No. 1 to Credit Agreement on August 12, 2026 - SEC Filing
THOMSON REUTERS  ·  08-12
Alkermes - Enters Amendment No. 1 to Credit Agreement on August 12, 2026 - SEC Filing
Alkermes - Amendment Reduces Interest Rate Spread Under Tla by 0.75% and Tlb by 0.50% - SEC Filing
THOMSON REUTERS  ·  08-12
Alkermes - Amendment Reduces Interest Rate Spread Under Tla by 0.75% and Tlb by 0.50% - SEC Filing
NeoGenomics Announces Planned Transition of General Counsel Role
TIPRANKS  ·  08-12
NeoGenomics Announces Planned Transition of General Counsel Role
Neurogene Advances Rett Gene Therapy Program and Extends Cash Runway to 2029
TIPRANKS  ·  08-11
Neurogene Advances Rett Gene Therapy Program and Extends Cash Runway to 2029

Introduction

Company Name.
First Trust NYSE Arca Biotechnology Index Fund
Affiliated Markets:
ARCA
Listing Date:
--
Main Business:
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of a cross section of small, mid and large capitalization companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.
Issue price:
--